TP53 and glioblastoma: A study employing array-based comparative genomic hybridization [11] revealed the overexpression of E3 ubiquitin ligase MDM2 in mouse glioblastoma, where MDM2 diminishes both the levels and activity of the critical tumor suppressor p53.